Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





IRON PENTACARBONYL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 13463-40-6; **Chemical Formula:** Fe(CO)5
OSHA previously had no exposure limit for iron pentacarbonyl. The ACGIH has a TLV-TWA of 0.1 ppm with a TLV-STEL of 0.2 ppm, measured as iron, for this highly flammable, oily, colorless to yellow liquid. The Agency proposed, and the final rule establishes, permissible exposure limits of 0.1 ppm TWA and 0.2 ppm STEL for iron pentacarbonyl, measured as Fe. NIOSH (Ex. 8-47, Table N1) concurs that these limits are appropriate.
In studies of rats, iron pentacarbonyl has been reported to have approximately one-third the acute toxicity of nickel carbonyl (for which the ACGIH has recommended a TLV of 0.05 ppm TWA) (Sunderman, West, and Kincaid 1959/Ex. 1-384). In 1970, Gage found that a 5.5-hour exposure at 33 ppm caused fatalities in three of eight rats; four of eight animals died after two 5.5-hour exposures at 18 ppm. At 7 ppm, no ill effects were observed in rats exposed 18 times in 5.5 hours (Gage 1970/ Ex. 1-318). There are no reports of long-term dose-response exposure studies in laboratory animals, and no evidence exists that iron pentacarbonyl is carcinogenic in either humans or animals (ACGIH 1986/Ex. 1-3, p. 327).
Immediate symptoms of acute exposure to high concentrations of iron pentacarbonyl include headache and dizziness, followed in 12 to 36 hours by fever, cyanosis, cough, and shortness of breath. Another clinical effect of overexposure to this substance is lung injury, and degenerative changes in the central nervous system have also been reported (ACGIH 1986/Ex. 1-3, p. 327). No comments (other than NIOSH’s) on the health effects of iron pentacarbonyl were submitted to the rulemaking record.
In the final rule, OSHA establishes a permissible exposure limit of 0.1 ppm TWA and a STEL of 0.2 ppm for iron pentacarbonyl. The Agency concludes that these limits will protect workers from the significant risks of material health impairment in the form of headache, dizziness, fever, dyspnea, cyanosis, pulmonary injury, and central nervous system effects, which are potentially associated with exposures at levels above the new limits.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue